- Previous Close
2.6200 - Open
2.6000 - Bid --
- Ask --
- Day's Range
2.5300 - 2.7200 - 52 Week Range
2.3100 - 5.8200 - Volume
53,834 - Avg. Volume
61,109 - Market Cap (intraday)
321.529M - Beta (5Y Monthly) -0.52
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3900 - Earnings Date May 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.85
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in White Plains, New York.
www.waldencast.com335
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WALD
View MorePerformance Overview: WALD
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WALD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WALD
View MoreValuation Measures
Market Cap
321.53M
Enterprise Value
488.83M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.05
Price/Book (mrq)
0.49
Enterprise Value/Revenue
1.78
Enterprise Value/EBITDA
17.07
Financial Highlights
Profitability and Income Statement
Profit Margin
-15.50%
Return on Assets (ttm)
-3.32%
Return on Equity (ttm)
-6.49%
Revenue (ttm)
273.87M
Net Income Avi to Common (ttm)
-42.44M
Diluted EPS (ttm)
-0.3900
Balance Sheet and Cash Flow
Total Cash (mrq)
14.8M
Total Debt/Equity (mrq)
24.95%
Levered Free Cash Flow (ttm)
8.34M